Top biotech in­vestor Pe­ter Kolchin­sky tees up a new SPAC — 3 days af­ter a $300M raise for ra­dio­phar­ma­ceu­ti­cals play

Three days af­ter RA Cap­i­tal founder Pe­ter Kolchin­sky steered his first SPAC in­to a $300 mil­lion raise for Point Bio­phar­ma’s late-stage ra­dio­phar­ma­ceu­ti­cals play, he’s teed up a new one.

As with all blank check plays, the de­tails are all bare bones right now. Kolchin­sky raised $130 mil­lion af­ter pric­ing at $10 a share — with a $30 mil­lion add-on — for this new SPAC, dubbed Re­search Al­liance II. And that will set up a sub­stan­tial re­verse raise for a biotech look­ing to go pub­lic.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.